Best Antibiotic Course Podcasts (2024)

1
Why Broad Spectrum Antibiotics Aren't Enough 31:38

3h ago31:38

31:38

Dr. Randy Aronson, aka "The Pet Vet", shares videos from his podcast, Paws, Reflect, and Heal. On the podcast, Dr. Randy shares his wealth of knowledge about holistic health and medicine for pets, while also hosting a variety of other extremely knowledgeable medical professionals. Whether you're a pet owner or not, this information is valuable for …

1
A Conversation with Brandon Burch, Director of AnimalBiome Veterinary 27:26

2h ago27:26

27:26

Dr. Randy Aronson, aka "The Pet Vet", shares videos from his podcast, Paws, Reflect, and Heal. On the podcast, Dr. Randy shares his wealth of knowledge about holistic health and medicine for pets, while also hosting a variety of other extremely knowledgeable medical professionals. Whether you're a pet owner or not, this information is valuable for …

1
A Conversation with Pet Trainer Paul Blaushild | Dr. Randy Pet Vet 15:52

18d ago15:52

15:52

Dr. Randy Aronson, aka Dr. Randy Pet Vet, and Pet Trainer Paul Blaushild sit down to discuss a variety of topics from training your pets, how much exercise they should be getting per breed, and what behaviors to look out for. Send in any questions you may have to randy@drrandypetvet.com and Dr. Randy will answer them in future episodes! Connect wit…

1
K.N.E.E., Animal Shelters, Pet Ownership, Puppy Socialization, Dog Training, and more 19:41

1M ago19:41

19:41

Dr, Randy Aronson, aka Dr. Randy Pet Vet, and Pet Trainer Paul Blaushild talk about a variety of topics in this episode. Some of the topics they cover are the acronym K.N.E.E. and what it means for your pets, animal shelters, pet ownership, puppy socialization, dog training, and more. Send in your questions to randy@drrandypetvet.com so Dr. Randy c…

1
A Conversation with Dr. Brian Cabin 19:14

2M ago19:14

19:14

In this episode, Dr. Randy and Dr. Brian Cabin discuss an array of topics ranging from nutrigenomics, your body's immune system, and how our bodies are affected by our diets. Dr. Randy Aronson and Dr. Brian Cabin break down the importance of our overall health and how it relates to our pets. Send in your questions so Dr. Randy can answer them in fu…

1
A Conversation with Dr. Brian Cabin - Prolozone, Ozone, Holistic Medicine 13:24

2M ago13:24

13:24

In this episode, Dr. Randy and Dr. Brian Cabin continue to discuss more topics related to our health and our pet's health like Prolozone, Ozone, the spiritual piece of holistic medicine, and more. Send in your questions so Dr. Randy can answer them in future podcast episodes! Connect with Dr. Randy on his website, social media pages, and all podcas…

1
P.E.T.S. 17:56

3M ago17:56

17:56

In this episode, I break down what the pneumonic P.E.T.S. means. Our pets are only living two-thirds of their life expectancy, which is scary. This is why understanding and putting P.E.T.S. into practice is so important. Proper diet and microbiome Exercise Training and socialization Stress reduction Connect with me on social: Facebook: @drrandypetv…

1
What is Integrative Medicine? 9:32

4M ago9:32

9:32

Dr. Randy Aronson - The Radio Pet Vet shares videos to inform and inspire you to take care of your pets using an integrative approach to diagnostics and therapies, while combining Western or allopathic medicine with holistic modalities. Connect with Dr. Randy on his website, social media pages, and all podcast platforms! https://drrandypetvet.com/ …

1
Understanding vaccine hesitancy in Europe 12:20

1y ago12:20

12:20

This week EURACTIV's health reporter Marta Iraola talks to Dr. Emilie Karafillakis about vaccine confidence in Europe and what is behind people's lack of trust in vaccination and public health campaigns. In this episode, the health team reunites before the summer to say goodbye to this podcast as from September health topics will be covered under B…

1
AI: at the Interface of computer science and Medicine 32:33

1y ago32:33

32:33

From YouTube-recommended videos to facial recognition used to unlock smartphones, AI is already being used on a daily basis. The healthcare sector is not an exception as its ability to process vast amounts of medical data helps in diagnostics and medical image analysis. To better understand where AI is already used and what potential it holds, EURA…

1
European Health Data Space on the Parliament's Plate 25:54

1y ago25:54

25:54

As the European Parliament debates how European health data space should be shaped, EURACTIV talks with the co-rapporteur of the file, Croatian MEP Tomislav Sokol (EPP), touching on primary and secondary use of data, the reasons why parliament supports the opt-out option and what is left to discuss before the discussions can start with the Council.…

1
Balancing patients' privacy and health data's potential 20:29

1y ago20:29

20:29

European Health Data Space (EHDS) focuses on the primary and secondary use of data. While the primary use of data is data used by citizens and healthcare professionals at the national and EU levels the secondary data is to be used by researchers, policy makers and pharma. The Commission's proposal does not include any say for patients regarding the…

1
The challenge of guaranteeing access to healthcare to all Ukrainian refugees 19:08

1y ago19:08

19:08

On the occasion of the first Healthcare Forum, which took place in Wąsowo, Poland last week, Euractiv spoke with the Regional Director of WHO/Europe, Dr Hans Kluge. In this interview, Dr. Kluge looked back on his meeting with the Polish and Ukrainian Ministers of Health about the Healthy Reconstruction of Ukraine. He dug into the physical and menta…

1
A closer look at Europe's fertility challenge 10:39

1y ago10:39

10:39

This week EURACTIV'S health team explores why fertility is decreasing across the globe, what challenges people face when they want children and the situation of fertility treatments in Europe. For that, Health Reporter Marta Iraola talks with Dr Carlos Calhaz-Jorge, a specialist in obstetrics and gynaecology and chair of the European Society for Hu…

1
Endocrine Disrupting Chemicals: a silent threat for children's development 14:07

1y ago14:07

14:07

This week, EURACTIV’s health team dives into how endocrine-disrupting chemicals (EDC) can affect children, especially in their most important developmental years. They talk with Doctor Anders Juul, a paediatric endocrinologist at Rigshospitalet in Copenhagen. He explains how children are exposed to these chemicals and the health issues this can cau…

1
Much more than a ‘party drug’ 35:43

1y ago35:43

35:43

Psilocybin, MDMA or LSD might associate with party drugs but their therapeutic value is being discovered worldwide. Ian Roullier took part in two clinical trials that looked at the effects of psilocybin on depression. Through his personal experience, Roullier shares his insights on psychedelic-assisted therapy, its potential value to patients and w…

1
The need to phase out tobacco farming 16:47

1y ago16:47

16:47

Tobacco is responsible for 8 million deaths a year but despite that governments across the world spend millions supporting tobacco farms, according to WHO Director-General Tedros Ghebreyesus. As 31 May marks World No Tobacco Day, EURACTIV’s health team talks with Rudiger Krech, WHO Director of the Health Promotion Department, on the impact of toxic…

1
Mental health matters in the Parliament 14:09

1y ago14:09

14:09

From psychedelics and mental health literature to having pets in EU institutions - EURACTIV’s health reporter Giedrė Peseckytė is talking with three MEPs - Maria Walsh from Christian Democrats, Mikuláš Peksa from the Greens and Karen Melchior from Renew - about mental health.By Euractiv

1
The Importance of early testing 21:26

1y ago21:26

21:26

As this week is European Testing Week, a European campaign that aims to increase testing efforts and promote awareness of the benefits of earlier hepatitis and HIV testing, EURACTIV's health team is talking with Jens Lundgren, Professor of infectious diseases at the University of Copenhagen in Denmark. He has been involved with clinical HIV researc…

1
Discovering Monderna's new landscape for vaccines in Europe 11:26

1y ago11:26

11:26

This week, EURACTIV’s health team talks with Chantal Friebertshäuser, Senior Vice President at Moderna for Europe, the Middle East and Canada. They discuss the end of COVID and the new vaccine they are developing against cancer. They also talk about the new facility the biotechnology company recently opened in Madrid, Spain. This new laboratory, eq…

1
Unwrapping the new pharmaceutical legislation 13:51

1y ago13:51

13:51

This week, EURACTIV’s health team dives into the proposal for a new pharmaceutical legislation and the complicated way ahead. For that, they talk with stakeholders working on health policy at the EU level about their priorities and main concerns.By Euractiv

1
Out of REACH 11:11

1y ago11:11

11:11

This week, EURACTIV’s health team dives into endocrine disruptors and the effect these chemicals can have on our hormonal system. They talk with Doctor Angel Nadal, professor of physiology at the University Miguel Hernandez in Spain, about the current framework and what else can be done at the EU level.…

1
Fact checking The Whale’s obesity portrayal 12:08

1+ y ago12:08

12:08

This week, EURACTIV’s journalist Marta Iraola talks about the movie ‘The Whale’ with Jacqueline Bowman-Busato, head of policy at the European Association for the Study of Obesity. They focus on the controversies about its portrayal of obesity and the reception among the patient community.By Euractiv

1
The crime of passing the pill 16:54

1+ y ago16:54

16:54

This week, EURACTIV’s journalist Giedrė Peseckytė is talking with a Polish pro-abortion activist Justyna Wydrzynska who got sentenced in mid-March to eight months of community service for sharing abortion pills with another woman back in 2020. *The interview was conducted on 23 March.By Euractiv

1
Ukraine's fight against TB 20:00

1+ y ago20:00

20:00

Marking world Tuberculosis day (24 March) we are talking with two Ukrainians about how Ukrainians are fighting not only Russia's invasion but also one of the highest incidences of TB cases in the European region.By Euractiv

1
The EU rules for sperm in SoHo 12:00

1+ y ago12:00

12:00

This week, EURACTIV’s health team explores the outstanding revision of the EU framework on substances of human origins (SoHo) together with Annemette Arndal-Lauritzen, CEO of the European Sperm Bank, with a focus on the revision of the EU rules for sperm donation.By Euractiv

1
Unboxing the EU’s medical devices rules 15:11

1+ y ago15:11

15:11

This week, EURACTIV's health journalists Marta Iraola and Gerardo Fortuna dig into the troubled implementation of the new framework for medical devices in Europe which entered into force in 2021. When developers of medical devices started experiencing problems in meeting the deadlines for implementing the key rules of the new regulation, the EU law…

1
Talking women's health with Kyriakides 16:31

1+ y ago16:31

16:31

This week, EURACTIV’s journalists Clara Bauer and Gerardo Fortuna sat with the EU’s health Commissioner Stella Kyriakides to talk about women’s health on the occasion of International Women’s Day. The EU health chief also gave some anticipations on what is coming up next in the EU’s health policy agenda.…

1
The Health Data Revolution 15:33

1+ y ago15:33

15:33

This week, EURACTIV’s health team brings you the nitty-gritty of the European Health Data Space together with one of the European Parliament's rapporteur on the file, the centre-right Croatian MEP Tomislav SokolBy Euractiv

1
Ongoing Pfizer saga 15:16

1+ y ago15:16

15:16

This week, EURACTIV's health team dig into the European Parliament’s role in the ongoing saga on the transparency of the COVID-19 vaccine contracts between the European Commission and the pharmaceutical company Pfizer with MEP Tilly Metz.By Euractiv

1
Episode 22: Pharmacy Benefit Managers (PBMs) and Their Hidden Role in Drug Pricing 40:06

2+ y ago40:06

40:06

Today on the show we take a look at the shadow world where pharmacy benefit managers or PBM’s operate to influence drug prices. Joining us is Antonio Ciaccia, the CEO of 46Brooklyn Research, an Ohio non-profit corporation whose purpose is to improve the accessibility and usability of U.S. drug pricing data. PBMs are a meaningful part of the US drug…

1
Episode 21: Antibiotic Resistance: How CARB-X Helps New Companies Get a Running Start 31:30

3y ago31:30

31:30

Kevin Outterson, the Executive Director of Boston-based CARB-X, a global non-profit partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria, joins the podcast to talk with Gunnar about the early-stage landscape for biotechnology companies developing novel antibiotics. Unlike the AMR…

1
Episode 20: Antibiotic Resistance: Bacteriophages, a Possible Answer? 30:49

3y ago30:49

30:49

The antibiotic resistance series on the State of Health has discussed, at length, the policy and market dysfunctions at the heart of the antibiotic crisis. This week, Gunnar talks with Dr. Ben Chan, an Associate Research Scientist in the department of Ecology and Evolutionary Biology at Yale University, and Ella Balasa, a cystic fibrosis patient ad…

1
Episode 19: Antibiotic Resistance: PASTEUR Act with Senator Michael Bennet 17:38

3y ago17:38

17:38

Senator Michael Bennet, a co-sponsor of the bipartisan PASTEUR Act, joins Gunnar on the State of Health to talk about his proposed legislation to correct the dysfunctional antibiotic market. Senator Bennet makes his pitch for why he believes people should care about antibiotic resistance, talks about how the PASTEUR Act can become law, and shares h…

1
Episode 18: Antibiotic Resistance: Investing in the Next Generation of Antibiotics 42:43

3y ago42:43

42:43

The State of Health continues the Antibiotic Resistance series with an episode featuring Henry Skinner, the CEO of the AMR Action Fund, a novel kind of investment fund that aims to catalyze the innovation ecosystem for novel antibiotics. Gunnar and Henry talk about the challenges of bringing new antibiotics to market, the difference between the AMR…

1
Episode 17: Antibiotic Resistance: PASTEUR Act with Senator Todd Young 15:25

3y ago15:25

15:25

Senator Todd Young from Indiana joins the podcast to talk about the PASTEUR Act, a bipartisan piece of legislation that he is co-sponsoring with Senator Michael Bennet that aims to reform the way novel antibiotics are paid for in the United States. Unlike most prescription drugs, antibiotics are unique in that they lose their efficacy over time tha…

1
Episode 16: Antibiotic Resistance: The Patient Experience 41:31

3y ago41:31

41:31

The State of Health is back after a brief summer vacation. This week, Emma D'Agostino, PhD joins the show to talk with Gunnar about their jointly written opinion piece that appeared in The Hill in mid-August entitled: New bipartisan legislation can encourage needed antibiotic development, where they called for bipartisan reform of the antibiotic ma…

1
Episode 15: Immunocompromised Transplant Patients Return to Vaccine Clinics for Booster Shots 26:56

3y ago26:56

26:56

Katy Monte, an immunocompromised woman who has received three transplants as a result of her end-stage cystic fibrosis, talks to Gunnar about getting a third COVID-19 vaccine after the FDA recommended booster shots for people who may not have developed antibodies after the initial doses. She explains the conversations she had with her care teams, h…

1
Episode 14: Huntington's Disease and Patient Advocacy with Seth Rotberg 35:00

3y ago35:00

35:00

Seth Rotberg joins the podcast to talk through the in's and out's of patient advocacy, the patient's role in drug development, and how patients can work with regulators to make sure the best possible medications reach approval. Since Gunnar considers himself a patient advocate, too, they are able to talk about their frustrations with the role, but …

1
Episode 13: Three Questions with Utah Governor Spencer Cox 21:56

3y ago21:56

21:56

In the end of summer 2020, Gunnar sat down to talk with then Lieutenant Governor Spencer Cox about the policymaker's connection with cystic fibrosis and the state's evolving response to COVID-19. Gunnar also solicits a question from a Utahan living with cystic fibrosis for the then Lieutenant Governor to answer. Gunnar talks about the need for soci…

1
Episode 12: The Future of the Drug Industry 26:52

3y ago26:52

26:52

Dr. Bill Smith, a visiting fellow in the life sciences at the Boston-based think tank, Pioneer Institute, and former drug industry veteran, joins the State of Health to talk about the evolving market dynamics in the drug industry starting with the Orphan Drug Act and the industry's rush into therapeutic development for rare diseases. In this episod…

1
Episode 11: Three Questions with Governor Mike Dunleavy (Alaska) 20:07

3y ago20:07

20:07

In this Three Questions episode where the role of the interviewer flips halfway through the show, Gunnar and Alaska Governor, Mike Dunleavy, talk about Alaska's early success with the state's vaccination campaign, the state's integrated health system and how Alaska's reliance on telehealth could be a playbook for other states as they look to normal…

1
Episode 10: Drug Access in Canada with Chris MacLeod 40:54

3y ago40:54

40:54

Chris MacLeod is a Canadian living with cystic fibrosis and practicing attorney, who has been a fierce advocate for patients who need access to life-sustaining medications or treatments. He founded the not-for-profit organization Canadian Cystic Fibrosis Treatment Society to assist in carrying out this work. He also recently released a book entitle…

1
Episode 9: Turning Hope into Action with Dr. David Fajgenbaum and the Castleman Disease Collaborative Network 26:24

3y ago26:24

26:24

Dr. David Fajgenbaum joins Gunnar on the podcast to talk about his New York Times Bestselling book, "Chasing My Cure: A Doctor’s Race to Turn Hope Into Action" and his journey from division 1 college football quarterback and medical student to a rare disease patient up against the clock to find a treatment for his suddenly diagnosed Castleman Disea…

1
Episode 8: Drug Pricing, Valuing Innovation and No Patient Left Behind with Peter Kolchinsky 53:17

3y ago53:17

53:17

Biotechnology investor, Peter Kolchinsky, joins the State of Health to talk with Gunnar about drug pricing. The conversation covers the long term view that when drugs go generic without undue delay, the value they provide to society is far greater than the short-run value that cost effectiveness analyses often show, which Peter details in his book,…

1
Episode 7: OpenNotes with Liz Salmi 28:43

3y ago28:43

28:43

Liz Salmi, a self-described "former punk rock drummer turned cancer patient, and now senior research strategist," joins the show to paint a successful case study of joint-patient, physician, and researcher advocacy. She tells the story about the data-driven and evidence-based case for "open progress notes" and the impact they can have on patient ca…

1
Episode 6: Ask Patients! Jen Horonjeff and the Savvy Co-op 28:25

3y ago28:25

28:25

Patient engagement is more than a buzzword for career and lifelong patients. The lived experience of chronic disease holds tangible value that is often exploited under the guise of altruism. What if patients could capture some of the value generated by the healthcare delivery system and industry? The State of Health welcomes one entrepreneur who is…

1
Episode 5: Three Questions with Bob Coughlin from MassBio 25:57

3y ago25:57

25:57

Gunnar Esiason and Bob Coughlin, the former CEO of MassBio, talk about the state of the biotechnology industry in the background of the COVID-19 pandemic. Bob shares why the biotechnology trade association is important for biotech companies in Massachusetts, before getting into the industry's reputation and how he thinks the pandemic will impact th…

1
Episode 4: Carmela Coyle and the California Hospital Association 33:49

3y ago33:49

33:49

Carmela Coyle, the President and CEO of the California Hospital Association joins Gunnar to talk about the state of hospitals in California. In this deep dive interview, Gunnar wants to how how the hospitals of tomorrow will be shaped by today's pandemic and if the hospital industry sees telehealth as a competitor in care delivery. Gunnar challenge…

1
Episode 3: Three Questions with Governor Mike Parson (MO) 22:00

3y ago22:00

22:00

Governor Mike Parson from Missouri joined Gunnar Esiason for a three questions chat where they talked health policy and rare diseases in Missouri. Gunnar shares a personal connection to St. Louis University School of Medicine, and then asks the Governor how the state is managing care for people with rare and complex diseases while hospitals stress …

Podcasts Worth a Listen

Antibiotic Course Podcasts

Podcasts Worth a Listen

Quick Reference Guide